Skip to content

Aortic-Stent-Register

Aortenstent-Register Thorakale Aorta

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01197651
Enrollment
199
Registered
2010-09-09
Start date
2008-10-31
Completion date
2011-10-31
Last updated
2016-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Dissection

Keywords

Aorta, Aorta-Stent-Graft, Surgical operation, Aortic dissection

Brief summary

The aims of the aorta-stent-Registry are: • participating hospitals (with audit) document all consecutive patients diagnosed with a disease of the distal thoracal aorta that receive one of the following therapies:

Detailed description

1. Endovascular Aorta-Stent-Graft 2. Surgical operation of the distal thoracal aorta * Documentation of the indications, the procedural results and the clinical short- and long-term results of the endovascular and chirurgical treatment in day to day hospital routine. * Documentation of the operational risk (Euroscore) * Documentation of the technical enforcement of the procedure as well as the result of the intervention * Documentation of the hospital lethality and the non-fatal serious complications (Spinal Cord Ischemia, SCI, Stroke, TIA, high blood loss etc.) * Documentation of medication at hospital discharge * Documentation of long-term lethality and non-fatal serious complications (SCI, Stroke, TIA, major bleeding etc.) as well as hospitalization, re-intervention rates and medicinal drug therapy after 30 days, 1, 3 & 5 years.

Interventions

None listed

Sponsors

Stiftung Institut fuer Herzinfarktforschung
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with significant illness of the distal thoracal aorta (distal Aortic-dissection; TAA; penetrated ulcer; covered perforation; traumatically transection of the distal thoracal aorta) including those that receive an endovascular stent or an open surgical operation.

Exclusion criteria

* Missing signed informed consent

Design outcomes

Primary

MeasureTime frame
◦Documentation of the indications, the procedural results and the clinical short- and long-term results of the endovascular and chirurgical treatment in day to day hospital routineHospital-stay

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026